paroxetine drug

Aliases

PAX, selective serotonin reuptake inhibitor

External links

DrugBank · PubChem

Related entities (3)

Mentioned in (13)

Papers in which this entity is mentioned.

• Canonical TGF-β signaling regulates the relationship between prenatal maternal depression and amygdala development in early life. (2021)
• Structural neuroimaging biomarkers for obsessive-compulsive disorder in the ENIGMA-OCD consortium: medication matters. (2020)
• Acquired Sleep-Related Hypermotor Epilepsy with Disrupted White Matter Tracts Assessed by Multishell Diffusion Magnetic Resonance Imaging. (2018)
• Smoothened determines β-arrestin-mediated removal of the G protein-coupled receptor Gpr161 from the primary cilium. (2016)
• Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats. (2015)
• A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION. (2015)
• Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes. (2014)
• Modeling transformations of neurodevelopmental sequences across mammalian species. (2013)
• The neural effects of psychotropic medications in children and adolescents. (2012)
• Recent research on impulsivity in individuals with drug use and mental health disorders: implications for alcoholism. (2010)
• Developmental origins of health and disease: environmental exposures. (2009)
• Fetal effects of psychoactive drugs. (2009)
• The error-related negativity (ERN) and psychopathology: toward an endophenotype. (2008)

Merged raw entities (3)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.